애드바이오텍
2,145KRWMarket close of 10/21 (Wed)
Up +9.10%+179KRWMarket close of 10/21 (Wed)
- Open
- 1,966
- High
- 2,250
- Low
- 1,900
- Day range
- Day range low 1,900 high 2,250, open 1,966, close 2,145, previous close 1,966
- Volume
- 15×10K shares
- 320.02 million KRW 0.70× the 20-session average
Market close of 10/21 (Wed)
Where it sits in the 1-year range
31%1-year close range 1,350 to 3,945 won, 31% up from the low
31% of the way up from the lowest close in 1 year (252 sessions) · -45.6% from the high
Something to check
2 to check: bigger daily move than usual · operating loss
Free · no sign-inSource from 2021-05-17
Points to check
- Daily moveto check+9.10%+9.10%, 2.4× the usual (20-session average ±3.87%)That day +9.10% · usual ±3.87% · large-move threshold ±7.7%
- Earningsto check-4.4B KRWOperating income over the last four quarters -4.4B KRW (loss)
- Recent filingsnot verifiedOutside filing data coverage, so not verified
The other 3
- Foreign & institutionalnot verified
- Trading value0.7×usual range
- Data date10/21 (Wed)Market close
See the full check report
Quarterly results · Q1 2026
- Revenue3.1B KRW
- vs. year ago
- -11.1%
- vs. prior quarter
- +3.4%
- Operating income-1.1B KRW
- vs. year ago
- Still a loss
- vs. prior quarter
- Turned to loss
- Operating margin-34.6%
- vs. year ago
- -28.8 pp
- vs. prior quarter
- -46.2 pp
Quarterly operating income trend
As of the latest official close · 2026-10-21Valuation filing date · 2026-05-15Same sector · 제약
Up +0.83%· 57 of 168 stocks up, preferred shares excluded · trading value 730.8B KRW
| Stock | 20D | Change | Trading value |
|---|---|---|---|
| 삼성바이오로직스 | Close over the last 20 sessions +1.5% | Up +1.87% | 166.1B KRW |
| 셀트리온 | Close over the last 20 sessions +9.6% | Up +0.10% | 119.2B KRW |
| 지투지바이오 | Close over the last 20 sessions +27.6% | Up +13.78% | 49.8B KRW |
| 삼익제약 | Close over the last 20 sessions -20.3% | Up +2.58% | 47.2B KRW |
| 유한양행 | Close over the last 20 sessions +11.7% | Up +0.46% | 35.3B KRW |
Schedule
- Next data 10/23 (Fri) after 08:50
Investor flows, financials and valuation are provided for 369 stocks. These stocks account for about 85% of trading value, about 92% of market capitalisation. Coverage status →
For information only, not a solicitation to invest. Investment decisions and their results are your own responsibility.